A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

Bone Marrow Transplantation

Volumn 47, Issue 12, 2012, Pages 1507-1512

  Xu, L P ^a   Liu, K Y ^a   Liu, D H ^a   Han, W ^a   Chen, H ^a   Chen, Y H ^a   Zhang, X H ^a   Wang, Y ^a   Wang, F R ^a   Wang, J Z ^a   Huang, X J ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

HSCT in SAA; severe acquired aplastic anemia; unmanipulated haploidentical transplantation; unmanipulated haploidentical transplantation in SAA

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ERYTHROPOIETIN; FOSCARNET; GANCICLOVIR; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STANOZOLOL; TESTOSTERONE UNDECANOATE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DONOR; DRUG TREATMENT FAILURE; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IN VITRO STUDY; INCIDENCE; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIBLING; STEM CELL MOBILIZATION; T CELL DEPLETION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HAPLOIDY; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; MALE; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84870823540     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.79     Document Type: Article

References (23)

1. Wagner JL, Deeg HJ, Seidel K, Anasetti C, Doney K, Sanders J et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. Transplantation 1996; 61: 54-61.
2. Locasciulli A, van' t Veer L, Hows J, Van Lint MT, Gluckman E, Nissen C et al. Bone marrow transplantation (BMT) in children with severe aplastic anemia (SAA) from donors other than HLA identical siblings. EBMT Working Party on Severe Aplastic Anemia. Bone Marrow Transplant 1991; 7(Suppl 3): 90-91.
3. Bacigalupo A, Hows J, Gordon-Simith EC, Gluckman E, Van Lint MT, Congiu M et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings. A report of the BMT Working Party. Bone Marrow Transplant 1988; 3: 531-535.
4. Woodard P, Cunningham JM, Benaim E, Chen X, Hale G, Horwitz E et al. Effective donor lymphohematopoietic reconstitution after haploidentical CD34\+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant 2004; 33: 411-418.
5. Passweg JR, Perez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 2006; 37: 641-649.
6. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006; 38: 291-297.
7. Liu D, Huang X, Liu K, Xu L, Chen H, Han W et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children. Biol Blood Marrow Transplant 2008; 14: 469-477.
8. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant 2009; 15: 257-265.
9. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976; 48: 63-70.
10. Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience. Semin Hematol 2000; 37: 69-80.
11. Fuhrer M. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anemia. Bone Marrow Transplant 2008; 42(Suppl 2): S97-S100.
12. Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23: 78-84.
13. Storb R, Deeg HJ. Failure of allogeneic canine marrow grafts after total-body irradiation. Allogeneic 'resistance' versus transfusion-induced sensitization. Transplantation 1986; 42: 571-580.
14. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A et al. Marrow transplantation in thirty 'untransfused' patients with severe aplastic anemia. Ann Intern Med 1980; 92: 30-36.
15. Anasetti C, Doney KC, Storb R, Meyers JD, Farewell VT, Buckner CD et al. Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty 'untransfused' patients. Ann Intern Med 1986; 104: 461-466.
16. Chan KW, Li CK, Worth LL, Chik KW, Jeha S, Shing MK et al. A fludarabine-based conditioning regimen for severe aplastic anemia. Bone Marrow Transplant 2001; 27: 125-128.
17. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socie G, Maury S et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005; 36: 947-950.
18. Vassiliou GS, Webb DK, Pamphilon D, Knapper S, Veys PA. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol 2001; 114: 701-705.
19. Tzeng CH, Chen PM, Fan S, Liu JH, Chiou TJ, Hsieh RK. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. Bone Marrow Transplant 1996; 18: 273-277.
20. Dulley FL, Vigorito AC, Aranha FJ, Sturaro D, Ruiz MA, Saboya R et al. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection. Bone Marrow Transplant 2004; 33: 9-13.
21. Xu LP, Liu KY, Liu DH, Chen H, Han W, Chen YH et al. The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis. Bone Marrow Transplant 2010; 45: 985-992.
22. Wang HX, Ji SQ, Chen HR, Yan HM, Liu J, Zhu L et al. Clinical study on hematopoietic reconstitution in patients with leukemia by haploidentical bone marrow transplantation. J Exp Hematol 2003; 11: 416-419.
23. Chen YH, Xu LP, Chen H, Liu DH, Liu KY, Huang XJ. A clinical analysis of HLA-identical hematopoietic stem cell transplantation for severe aplastic anemia. Chinese J Int Med 2009; 48: 1031-1034.